Literature DB >> 16959181

Urinary and Serologic Markers forInterstitial Cystitis: An Update.

David R Wilkinson1, And Deborah R Erickson.   

Abstract

This update reviews the published literature from the past 2 years pertaining to urinary and serum markers for interstitial cystitis (IC). Literature on markers described before 2004 also is included when needed to provide background information for the current literature. The markers that have been the focus of the most research in the recent literature are antiproliferative factor, epidermal growth factor, heparin-binding epidermal growth factor-like growth factor, glycosaminoglycans, and bladder nitric oxide. These markers are discussed in consideration of their three different possible roles: 1) as diagnostic markers of IC; 2) distinguishing relevant subsets of IC patients; and 3) measuring disease activity and objectively following treatment response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959181     DOI: 10.1007/s11934-006-0013-1

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  46 in total

1.  Intravesical nitric oxide production discriminates between classic and nonulcer interstitial cystitis.

Authors:  Y R Logadottir; Ingrid Ehren; Magnus Fall; N Peter Wiklund; Ralph Peeker; Philip M Hanno
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

2.  Decreased in vitro proliferation of bladder epithelial cells from patients with interstitial cystitis.

Authors:  Susan Keay; Chen-Ou Zhang; Joanna L Shoenfelt; Toby C Chai
Journal:  Urology       Date:  2003-06       Impact factor: 2.649

3.  Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis?

Authors:  Deborah R Erickson; John E Tomaszewski; Allen R Kunselman; Christina M Bentley; Kenneth M Peters; Eric S Rovner; Laurence M Demers; Marcia A Wheeler; Susan K Keay
Journal:  J Urol       Date:  2005-01       Impact factor: 7.450

4.  Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis.

Authors:  S K Keay; C O Zhang; J Shoenfelt; D R Erickson; K Whitmore; J W Warren; R Marvel; T Chai
Journal:  Urology       Date:  2001-06       Impact factor: 2.649

5.  Ultrastructural characteristics of rat peritoneal mast cells undergoing differential release of serotonin without histamine and without degranulation.

Authors:  S Kraeuter Kops; T C Theoharides; C T Cronin; M G Kashgarian; P W Askenase
Journal:  Cell Tissue Res       Date:  1990-12       Impact factor: 5.249

6.  Altered inducible nitric oxide synthase expression and nitric oxide production in the bladder of cats with feline interstitial cystitis.

Authors:  L A Birder; A Wolf-Johnston; C A Buffington; J R Roppolo; W C de Groat; A J Kanai
Journal:  J Urol       Date:  2005-02       Impact factor: 7.450

7.  Comparison of APF activity and epithelial growth factor levels in urine from Chinese, African-American, and white American patients with interstitial cystitis.

Authors:  Chen-O u Zhang; Ze-Liang Li; Joanna L Shoenfelt; Chui-Ze Kong; Toby C Chai; Deborah R Erickson; Kenneth M Peters; Eric S Rovner; Susan Keay
Journal:  Urology       Date:  2003-05       Impact factor: 2.649

Review 8.  Critical role of mast cells in inflammatory diseases and the effect of acute stress.

Authors:  Theoharis C Theoharides; David E Cochrane
Journal:  J Neuroimmunol       Date:  2004-01       Impact factor: 3.478

9.  The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study.

Authors:  P M Hanno; J R Landis; Y Matthews-Cook; J Kusek; L Nyberg
Journal:  J Urol       Date:  1999-02       Impact factor: 7.450

10.  APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis.

Authors:  Chen-Ou Zhang; Ze-Liang Li; Chui-Ze Kong
Journal:  BMC Urol       Date:  2005-04-29       Impact factor: 2.264

View more
  7 in total

Review 1.  Implications for bidirectional signaling between afferent nerves and urothelial cells-ICI-RS 2014.

Authors:  Anthony Kanai; Christopher Fry; Youko Ikeda; Florenta Aura Kullmann; Brian Parsons; Lori Birder
Journal:  Neurourol Urodyn       Date:  2016-02       Impact factor: 2.696

2.  Fine structural characterization of chondroitin sulfate in urine of bladder pain syndrome subjects.

Authors:  Francesca Maccari; Dania Buzzega; Fabio Galeotti; Nicola Volpi
Journal:  Int Urogynecol J       Date:  2011-08-02       Impact factor: 2.894

3.  A candidate serum biomarker for bladder pain syndrome/interstitial cystitis.

Authors:  Daniel E Rubio-Diaz; Megan E Pozza; Jordan Dimitrakov; Jason P Gilleran; M Monica Giusti; Judith L Stella; Luis E Rodriguez-Saona; C A Tony Buffington
Journal:  Analyst       Date:  2009-04-16       Impact factor: 4.616

4.  The Challenges of Interstitial Cystitis: Current Status and Future Prospects.

Authors:  Samuel Belknap; Eric Blalock; Deborah Erickson
Journal:  Drugs       Date:  2015-12       Impact factor: 9.546

Review 5.  Pathomechanism of Interstitial Cystitis/Bladder Pain Syndrome and Mapping the Heterogeneity of Disease.

Authors:  Jia-Fong Jhang; Hann-Chorng Kuo
Journal:  Int Neurourol J       Date:  2016-11-22       Impact factor: 2.835

Review 6.  Metabolomics in Central Sensitivity Syndromes.

Authors:  Joseph S Miller; Luis Rodriguez-Saona; Kevin V Hackshaw
Journal:  Metabolites       Date:  2020-04-24

7.  Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis/bladder pain syndrome.

Authors:  Yuan-Hong Jiang; Chung-Hsin Peng; Hsin-Tzu Liu; Hann-Chorng Kuo
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.